Kenfarb & Co’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$2.24M Sell
4,421
-30
-0.7% -$16K 2.05% 9
2023
Q2
$2.32M Sell
4,451
-10
-0.2% -$5.4K 2.02% 11
2023
Q1
$2.57M Sell
4,461
-165
-4% -$93K 2.3% 9
2022
Q4
$2.55M Hold
4,626
2.26% 8
2022
Q3
$2.35M Hold
4,626
2.23% 10
2022
Q2
$2.73M Hold
4,626
2.16% 10
2022
Q1
$2.73M Buy
4,626
+455
+11% +$261K 2.16% 10
2021
Q4
$2.78M Buy
+4,171
New +$2.6M 2.03% 12

Other funds holding TMO

Kenfarb & Co's TMO Position: Q3 2023 in Review

Kenfarb & Co reduced its Thermo Fisher Scientific (TMO) stake by 0.67% in Q3 2023, selling an estimated $16K and leaving 4,421 shares worth $2.24M. The position accounts for 2.05% of the portfolio, ranked #9.

Kenfarb & Co first reported a position in TMO in Q4 2021 and has held it in 8 quarters since. The position peaked at $2.78M in Q4 2021. 2,364 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

  • Kenfarb & Co held 4,421 shares of Thermo Fisher Scientific worth $2.24M as of Q3 2023.
  • Kenfarb & Co sold 30 Thermo Fisher Scientific shares in Q3 2023, an estimated $16K.
  • Thermo Fisher Scientific made up 2.05% of Kenfarb & Co's portfolio in Q3 2023, its #9 holding.
  • Kenfarb & Co first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 8 quarters since.
  • Kenfarb & Co's Thermo Fisher Scientific position peaked at $2.78M in Q4 2021.
  • 2,364 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Kenfarb & Co's 13F filing for Q3 2023, filed 14 Nov 2023.